6
J.S. Dhau et al. / Tetrahedron xxx (2014) 1e8
[Found: C, 56.27; H, 7.30; N, 7.49. C18H28N2O2Se requires C, 56.38;
iodoethane (0.983 g, 0.51 mL, 6.3 mmol), and hydrolysis gave 5a as
a brown crystalline solid (0.78 g, 58%); Mp 40e42 ꢂC; [Found: C,
57.37; H, 7.96; N, 9.55. C21H35N3O2Se requires C, 57.26; H, 8.00; N,
9.53%]; Rf (30% EtOAc/hexane) 0.66; 1H NMR (400 MHz, CDCl3):
H, 7.36; N, 7.30%]; Rf (30% EtOAc/hexane) 0.90; 1H NMR (400 MHz,
CDCl3):
d
¼7.83e7.81 (d, 1H, 3J¼8.2 Hz, CHAr(4)), 7.74e7.72 (d, 1H, d,
3J¼8.2 Hz, CHAr(3)), 3.61e3.50 (m, 2H, CH), 3.08e3.05 (t, 2H, CH2),
2.28 (s, 3H, SeCH3), 1.62e1.61 (m, 2H, CH2), 1.54e1.53 (d, 6H,
3J¼6.8 Hz, CH3), 1.34e1.32 (m, 2H, CH2), 1.14e1.12 (d, 6H, 3J¼6.7 Hz,
CH3), 0.87e0.83 (t, 3H, CH3) ppm; 13C NMR (100 MHz, CDCl3):
d
¼7.86e7.84 (d, 1H, 3J¼8.1 Hz, CHAr(4)), 7.49e7.47 (d, 1H, d,
3J¼8.1 Hz, CHAr(3)), 4.016e4.13 (m, 1H, CH), 3.60e3.49 (m, 3H, CH),
2.98e2.93 (q, 2H, SeCH2), 1.57e1.55 (d, 6H, 3J¼6.8 Hz, CH3),
1.52e1.50 (d, 6H, 3J¼6.8 Hz, CH3), 1.45e1.40 (t, 3H, CH3), 1.19e1.17
(d, 6H, 3J¼6.6 Hz, CH3), 1.15e1.13 (d, 6H, 3J¼6.6 Hz, CH3) ppm; 13C
d
¼200.7, 166.1, 153.2, 148.3, 136.3, 132.7, 120.5 49.8, 45.2, 36.2, 25.2,
21.4, 19.7, 19.3, 12.9, 5.6 ppm; IR (KBr)
n
¼3060, 2960, 2871, 1701,
1628, 1551,1464,1411,1207 cmꢁ1; UVevis (CHCl3): lmax (log ε)¼327
(3.8), 250 (3.5) nm; MS (ESI) m/z¼385 [Mþ1(80Se)]þ.
NMR (100 MHz, CDCl3):
123.2, 51.0, 50.9, 46.2, 45.9, 20.9, 20.7, 20.5, 20.4, 20.2, 15.0 ppm; IR
d
¼167.8, 167.5, 155.3, 152.7, 140.5, 126.1,
(KBr)
n
¼3057, 2963, 2867, 1621, 1559, 1461, 1445, 1417, 1210,
4.4. Preparation of (methyltelluryl) derivatives of 1
1038 cmꢁ1; UVevis (CHCl3): lmax (log ε)¼311 (4.0), 287 (4.1), 253
(4.0) nm; MS (ESI) m/z¼464 [MþNa (80Se)]þ.
Treatment of 1-Te with 6.3 mmol of iodomethane (0.894 g,
0.38 mL) yielded three different products, 0.67 g (47%) 2b, 0.11 g
(6%) 3b and 0.26 g (20%) 4b. However, the use of 6.1 equiv of n-BuLi
(7.56 mL, 18.9 mmol, 2.5 N) or 4.1 equiv of LDA (12.3 mmol) ex-
clusively gave 2b in 77% (1.10 g) and 75% (1.06 g) yield, respectively.
4.6. N,N,N0,N0-Tetraisopropyl-3-(propylselenenyl)pyridine-2,6-
dicarboxamide (6a)
The use of bromopropane (0.775 g, 0.57 mL, 6.3 mmol) instead
of iodomethane in the above reaction gave 6a as a yellow crystalline
solid (0.79 g, 58%). Mp 104e105 ꢂC; [Found: C, 58.26; H, 8.23; N,
9.23. C22H37N3O2Se requires C, 58.13; H, 8.20; N, 9.24%]; Rf (30%
4.4.1. N,N,N0,N0-Tetraisopropyl-3-(methyltelluryl)pyridine-2,6-
dicarboxamide (2b). Yellow crystalline solid, Mp 135e137 ꢂC;
[Found: C, 56.63; H, 7.05; N, 8.80. C20H33N3O2Te requires C, 56.56;
H, 7.00; N, 8.84%]; Rf (30% EtOAc/hexane) 0.60; 1H NMR (400 MHz,
EtOAc/hexane) 0.67; 1H NMR (400 MHz, CDCl3):
d
¼7.79e7.77 (d,
1H, 3J¼8.1 Hz, CHAr(4)), 7.41e7.39 (d, 1H, d, 3J¼8.1 Hz, CHAr(3)),
4.10e4.07 (m, 1H, CH), 3.52e3.42 (m, 3H, CH), 2.87e2.83 (t, 2H,
SeCH2), 1.69e1.60(m, 2H, CH2), 1.50e1.48 (d, 6H, 3J¼6.8 Hz, CH3),
1.46e1.44 (d, 6H, 3J¼6.8 Hz, CH3), 1.12e1.10 (d, 6H, 3J¼6.6 Hz, CH3),
CDCl3):
d
¼7.86e7.84 (d, 1H, 3J¼8.0 Hz, CHAr(4)), 7.32e7.30 (d, 1H, d,
3J¼8.0 Hz, CHAr(3)), 3.91e3.83 (m, 2H, CH), 3.48e3.43 (m, 2H, CH),
1.99 (s, 3H, TeCH3), 1.48e1.46 (d, 6H, 3J¼6.8 Hz, CH3), 1.46e1.44 (d,
6H, 3J¼6.8 Hz, CH3), 1.11e1.09 (d, 6H, 3J¼6.4 Hz, CH3), 1.09e1.08 (d,
1.08e1.06 (d, 6H, 3J¼6.6 Hz, CH3), 0.95e0.91 (t, 3H, CH3) ppm; 13
C
6H, 3J¼6.4 Hz, CH3) ppm; 13C NMR (100 MHz, CDCl3):
d¼167.8,167.1,
NMR (100 MHz, CDCl3):
123.3, 51.0, 50.9, 46.2, 45.9, 29.5, 23.1, 20.7, 20.5, 20.4, 20.3,
d
¼167.8, 167.5, 155.3, 152.7, 140.6, 126.5,
154.4, 151.2, 141.9, 122.2, 112.3 49.9, 45.2, 45.1, 19.7, 19.6, 19.4, 19.3,
ꢁ17.1 ppm; 125Te NMR (400 MHz, CDCl3):
d¼315.0 ppm; IR (KBr)
14.4 ppm; IR (KBr)
n
¼2965, 2930, 2872,1624, 1457, 1441, 1205, 1150,
n
¼3061, 2971, 2871, 1616, 1556, 1460, 1417, 1208, 1035 cm-1; UVevis
1132, 1104, 1040, 1028 cmꢁ1; UVevis (CHCl3): lmax (log ε)¼312
(4.0), 286 (4.0), 252 (4.0) nm; MS (EI): m/z¼455 [M (80Se)]þ.
(CHCl3): lmax (log ε)¼332 (3.7), 291 (3.8), 252 (4.0) nm; MS (ESI) m/
z¼500 [MþNa (130Te)]þ.
4.7. 3-(Butylselenenyl)-N,N,N0,N0-tetraisopropylpyridine-2,6-
dicarboxamide (7a)
4.4.2. N,N,N0,N0-Tetraisopropyl-3,5-bis(methyltelluryl)pyridine-2,6-
dicarboxamide (3b). Yellow crystalline solid, Mp 158e159 ꢂC;
[Found: C, 40.83; H, 5.70; N, 6.83. C21H35N3O2Te2 requires C, 40.89; H,
5.72; N, 6.81%]; Rf (30% EtOAc/hexane) 0.75; 1H NMR (400 MHz,
Theuseof1 (0.999 g, 3.0 mmol), n-BuLi (7.32 mL,18.3 mmol, 2.5 N),
selenium (1.445 g, 18.3 mmol), iodobutane (3.477 g, 2.16 mL,
18.3 mmol), and hydrolysis gave7aas ayellowcrystalline solid (1.04 g,
74%). Mp 84e85 ꢂC; [Found: C, 59.09; H, 8.30; N, 8.99. C23H39N3O2Se
requires C, 58.95; H, 8.38; N, 8.96%]; Rf (30% EtOAc/hexane) 0.70; 1H
CDCl3):
d
¼7.98 (s, 1H, CHAr(4)), 4.00e3.97 (m, 2H, CH), 3.53e3.50 (m,
2H, CH), 2.06 (s, 6H, SeCH3), 1.54e1.52 (d, 12H, 3J¼6.8 Hz, CH3),
1.18e1.16 (d, 12H, 3J¼6.7 Hz, CH3) ppm; 13C NMR (100 MHz, CDCl3):
d
¼168.6, 153.0, 146.9, 114.1, 51.0, 46.3, 20.8, 20.4, ꢁ16.0 ppm; 125Te
NMR (400 MHz, CDCl3):
d
¼7.79e7.77 (d, 1H, 3J¼8.1 Hz, CHAr(4)),
NMR (400 MHz, CDCl3):
d¼327.2 ppm; IR (KBr)
n¼3058, 2964, 2870,
7.42e7.40 (d, 1H, d, 3J¼8.1 Hz, CHAr(3)), 4.10e4.07 (m, 1H, CH),
3.51e3.42 (m, 3H, CH), 2.89e2.85 (t, 2H, SeCH2), 1.63e1.56 (m, 2H,
1691,1617,1542,1446,1409,1208 cmꢁ1; UVevis (CHCl3): lmax (log ε)¼
321 (3.8), 295 (3.7), 253 (3.9) nm; MS (ESI) m/z¼644 [MþNa (130Te)]þ.
CH2), 1.50e1.48 (d, 6H, 3J¼6.8 Hz, CH3), 1.45e1.43 (d, 6H, J¼6.8 Hz,
3
CH3), 1.38e1.32 (m, 2H, CH2), 1.12e1.10 (d, 6H, 3J¼6.6 Hz, CH3),
4.4.3. N,N-Diisopropyl-3-(methyltelluryl)-6-pentanoylpicolinamide
(4b). Yellow crystalline solid Mp 92e94 ꢂC; [Found: C, 50.17; H,
6.60; N, 6.45. C18H28N2O2Te requires C, 50.04; H, 6.53; N, 6.48%]; Rf
1.08e1.06 (d, 6H, 3J¼6.6 Hz, CH3), 0.85e0.82 (t, 3H, CH3) ppm; 13C
NMR (100 MHz, CDCl3):
d¼167.8, 167.5, 155.2, 152.6, 140.4, 126.6,
123.3, 51.0, 50.9, 46.2, 45.9, 31.8, 27.1, 22.9, 20.7, 20.5, 20.4, 20.3,
(30% EtOAc/hexane) 0.87; 1H NMR (400 MHz, CDCl3):
d
¼7.92e7.90
13.5 ppm; IR (KBr)
n
¼2962, 2929, 2871, 1628, 1457, 1441, 1418, 1258,
(d, 1H, 3J¼8.1 Hz, CHAr(4)), 7.75e7.73 (d, 1H, d, 3J¼8.1 Hz, CHAr(3)),
4.04e4.01 (m, 1H, CH), 3.54e3.51 (m, 1H, CH), 3.07e3.04 (t, 2H,
CH2), 2.00 (s, 3H, TeCH3), 1.65e1.57 (m, 2H, CH2), 1.55e1.51 (d, 6H,
3J¼6.8 Hz, CH3), 1.35e1.27 (m, 2H, CH2), 1.19e1.17 (d, 6H, 3J¼6.6 Hz,
CH3), 0.88e0.87 (t, 3H, CH3) ppm; 13C NMR (100 MHz, CDCl3):
1207, 1153, 1134, 1105, 1036 cmꢁ1; UVevis (CH3OH): lmax (log ε)¼315
(3.8), 286 (3.9), 249 (3.9) nm; MS (EI): m/z¼469 [M (80Se)]þ.
4.8. 3-(Benzylselenenyl)-N,N,N0,N0-tetraisopropylpyridine-2,6-
dicarboxamide (8a)
d
¼201.8, 168.3, 157.8, 149.4, 142.3, 121.5, 120.6, 50.8, 46.5, 37.2, 26.1,
22.5, 20.9, 20.4, 13.9, ꢁ15.6 ppm; IR (KBr)
n
¼3058, 2964, 2870, 1691,
According to general procedure, the use of 1 (0.999 g, 3.0 mmol),
n-BuLi (2.52 mL, 6.3 mmol, 2.5 N), selenium (0.497 g, 6.3 mmol),
(chloromethyl)benzene (0.797 g, 0.72 mL, 6.3 mmol) and hydrolysis
gave 8a as a yellow crystalline solid (0.81 g, 54%). Mp 92e96 ꢂC;
[Found: C, 62.11; H, 7.47; N, 8.43. C26H37N3O2Se requires C, 62.13; H,
7.42; N, 8.36%]; Rf (30% EtOAc/hexane) 0.72; 1H NMR (400 MHz,
1617, 1542, 1446, 1409, 1208 cmꢁ1; UVevis (CHCl3): lmax (log ε)¼
364 (3.6), 253 (3.8) nm; MS (ESI) m/z¼457 [MþNa (130Te)]þ.
4.5. 3-(Ethylselenenyl)-N,N,N0,N0-tetraisopropylpyridine-2,6-
dicarboxamide (5a)
CDCl3):
d
¼7.73e7.71 (d, 1H, 3J¼8.0 Hz, Ar), 7.38e7.36 (d, 1H, d,
According to general procedure, the use of 1 (0.999 g, 3.0 mmol),
n-BuLi (2.52 mL, 6.3 mmol, 2.5 N), selenium (0.497 g, 6.3 mmol),
3J¼8.0 Hz, Ar), 7.27e7.17 (5H, m, Ar), 4.09e4.06 (m, 1H, CH), 4.18 (s,
2H, SeCH2), 3.54e3.48 (m, 3H, CH), 1.58e1.56 (d, 6H, 3J¼6.7 Hz,